Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kerodex is a specialized pharmaceutical and consumer health company focused on the manufacture and distribution of protective barrier creams designed to prevent occupational and contact dermatitis. The company's product line is engineered to provide a physical shield against various irritants, including water-based solutions, oils, solvents, and industrial chemicals. Kerodex products are widely utilized in industrial, clinical, and domestic settings to maintain skin integrity and prevent inflammatory skin conditions. While historically associated with larger pharmaceutical entities like Ayerst Laboratories, the brand continues to operate as a dedicated provider of dermatological protection solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kerodex.